Stay updated on Galcanezumab for Vestibular Migraine Clinical Trial
Sign up to get notified when there's something new on the Galcanezumab for Vestibular Migraine Clinical Trial page.

Latest updates to the Galcanezumab for Vestibular Migraine Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedA new revision tag (v3.3.2) was added to the record history, replacing the previous v3.2.0. This is a metadata update and does not change study details or results.SummaryDifference0.1%

- Check20 days agoChange DetectedRemoved the notice about lapse in government funding and NIH operating status from the page.SummaryDifference0.7%

- Check35 days agoChange DetectedVersion 10 (2024-11-15) updates the record with revised Study Status and adds Outcome Measures, Baseline Characteristics, and Adverse Events sections to the study record.SummaryDifference0.1%

- Check63 days agoChange DetectedMajor update: announces a version upgrade to v3.2.0 and publicly states funding-related operational notices, including that transactions may not be processed until appropriations are enacted.SummaryDifference12%

- Check70 days agoChange DetectedVersion update: from v3.0.2 to v3.1.0. The change is limited to the revision label; no core content or critical data appears to be altered.SummaryDifference0.3%

- Check84 days agoChange DetectedUpgrade from v3.0.1 to v3.0.2 is the primary change, and the 'Back to Top' element was removed. There are no changes to core content, pricing, stock, or time-slot information.SummaryDifference0.7%

Stay in the know with updates to Galcanezumab for Vestibular Migraine Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Galcanezumab for Vestibular Migraine Clinical Trial page.